BDO Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$19.4K Hold
138
﹤0.01% 576
2023
Q1
$19.5K Hold
138
﹤0.01% 585
2022
Q4
$21.6K Hold
138
﹤0.01% 566
2022
Q3
$17K Hold
138
﹤0.01% 601
2022
Q2
$18K Hold
138
﹤0.01% 579
2022
Q1
$19K Hold
138
﹤0.01% 600
2021
Q4
$24K Hold
138
﹤0.01% 584
2021
Q3
$20K Sell
138
-6
-4% -$878 ﹤0.01% 610
2021
Q2
$19K Hold
144
﹤0.01% 633
2021
Q1
$18K Sell
144
-8
-5% -$986 ﹤0.01% 629
2020
Q4
$18K Buy
152
+121
+390% +$14.8K ﹤0.01% 473
2020
Q3
$4K Buy
+31
New +$3.66K ﹤0.01% 580
2020
Q2
Sell
-200
Closed -$16K 709
2020
Q1
$16K Buy
+200
New +$20.7K ﹤0.01% 480

Other funds holding DGX

BDO Wealth Advisors's DGX Position: Q2 2023 in Review

BDO Wealth Advisors held its Quest Diagnostics (DGX) position steady in Q2 2023 at 138 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

BDO Wealth Advisors first reported a position in DGX in Q1 2020 and has held it in 13 quarters since. The position peaked at $24K in Q4 2021. 819 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • BDO Wealth Advisors held 138 shares of Quest Diagnostics worth $19.4K as of Q2 2023.
  • BDO Wealth Advisors left its Quest Diagnostics share count unchanged in Q2 2023.
  • Quest Diagnostics made up ﹤0.01% of BDO Wealth Advisors's portfolio in Q2 2023, its #576 holding.
  • BDO Wealth Advisors first reported a position in Quest Diagnostics in Q1 2020 and has held it in 13 quarters since.
  • BDO Wealth Advisors's Quest Diagnostics position peaked at $24K in Q4 2021.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on BDO Wealth Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.